NFKB1 and metabolic dysfunction-associated steatohepatitis: Compelling evidence indicates a critical role for the activation of the nuclear factor κB (NF-κB) of transcription factors in the progression from simple steatosis to NASH and the other MAFLD-related liver complications, but its contribution to the initiation of hepatic steatosis remains undefined [[5], [6], [7]].